CD Biosynsis designs and creates cell factories for target products based on the principles of synthetic biology. We design and modify the metabolic flow and regulatory networks at the whole-cell level, modularization, and regionalization of natural product synthesis pathways, and target product transport systems to improve the yield of cell factories.
Natural compounds are considered a gift from nature to mankind, and more than the average drug small molecule is derived from natural products and their analogs. These include penicillin and adriamycin, which are of microbial origin, and artemisinin and morphine, which are of plant origin. However, natural products are very low in nature and difficult to obtain in large quantities through isolation. CD Biosynsis is dedicated to providing novel strategies for the large-scale production of natural compounds and the design and synthesis of small molecule compounds with new structures through synthetic biology techniques.
Figure 1. The overall biosynthetic pathways for producing representative natural products in Escherichia coli. (Yang D, et al., 2020)
With the elucidation of biosynthetic pathways of some important natural compounds, we are able to reconstruct the heterologous synthesis pathways of natural compounds in microbial chassis cells and systematically optimize the cell factories for the efficient production of natural compounds. We have successfully achieved the biosynthesis of the following natural compounds.
CD Biosynsis provides the most comprehensive and efficient solutions for synthetic biology workflows. We are committed to helping our customers solve all problems encountered in natural compound production to advance their applications in a wide range of fields. Each of our deliverables will undergo a rigorous quality inspection test to ensure the reliability and accuracy of the results. If you are interested in our services or have any further questions, please do not hesitate to contact us.